Impact of ventricular assist device placement on longitudinal renal function in children with end-stage heart failure

被引:18
|
作者
May, Lindsay J. [1 ]
Montez-Rath, Maria E. [2 ]
Yeh, Justin [3 ]
Axelrod, David M. [4 ]
Chen, Sharon [4 ]
Maeda, Katsuhide [5 ]
Almond, Christopher S. D. [4 ]
Rosenthal, David N. [4 ]
Hollander, Seth A. [4 ]
Sutherland, Scott M. [6 ]
机构
[1] Univ Utah, Sch Med, Dept Pediat, Div Pediat Cardiol, Salt Lake City, UT USA
[2] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94304 USA
[3] Univ Calif San Diego, Dept Pediat, Div Pediat Cardiol, La Jolla, CA 92093 USA
[4] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Palo Alto, CA 94304 USA
[5] Stanford Univ, Dept Cardiothorac Surg, Div Pediat Cardiac Surg, Palo Alto, CA 94304 USA
[6] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, Palo Alto, CA 94304 USA
来源
关键词
ventricular assist device; end-organ dysfunction; renal function; children; end-stage heart failure; ACUTE KIDNEY INJURY; MECHANICAL CIRCULATORY SUPPORT; GLOMERULAR-FILTRATION-RATE; CONTINUOUS-FLOW; CARDIAC-SURGERY; CARDIORENAL SYNDROME; OUTCOMES; TRANSPLANTATION; IMPLANTATION; RISK;
D O I
10.1016/j.healun.2015.10.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although ventricular assist devices (VADs) restore hemodynamics in those with heart failure, reversibility of end-organ dysfunction with VAD support is not well characterized. Renal function often improves in adults after VAD placement, but this has not been comprehensively explored in children. METHODS: Sixty-three children on VAD support were studied. Acute kidney injury (AKI) was defined by Kidney Disease: Improving Global Outcomes criteria. Estimated glomerular filtration rate (eGFR) was determined by the Schwartz method. Generalized linear mixed-effects models compared the pre-VAD and post-VAD eGFR for the cohort and sub-groups with and without pre-VAD renal dysfunction (pre-VAD eGFR < 90 ml/min/1.73 m(2)). RESULTS: The pre-VAD eGFR across the cohort was 84.0 ml/min/1.73 m(2) (interquartile range [IQR] 62.3-122.7), and 55.6% (34 of 63) had pre-VAD renal dysfunction. AKI affected 60.3% (38 of 63), with similar rates in those with and without pre-existing renal dysfunction. Within the cohort, the nadir eGFR occurred 1 day post-operatively (62.9 ml/min/1.73 m(2); IQR, 51.2-88.9 ml/min/1.73 m(2); p < 0.001). By Day 5, however, the eGFR exceeded the baseline (99.0 ml/min/1.73 m(2); IQR, 59.3-146.7 ml/min/1.73 m(2); p = 0.03) and remained significantly higher through the first post-operative week. After adjusting for age, gender, and AKI, the eGFR continued to increase throughout the entire 180-day study period (beta = 0.0025; 95% confidence interval, 0.0015-0.0036; p < 0.001). Patients with pre-VAD renal dysfunction experienced the greatest improvement in the eGFR (beta = 0.0051 vs beta = 0.0013, p < 0.001). CONCLUSIONS: Renal dysfunction is prevalent in children with heart failure undergoing VAD placement. Although peri-operative AKI is common, renal function improves substantially in the first post-operative week and for months thereafter. This is particularly pronounced in those with pre-VAD renal impairment, suggesting that VADs may facilitate recovery and maintenance of kidney function in children with advanced heart failure. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:449 / 456
页数:8
相关论文
共 50 条
  • [11] Hypomagnesemia after heart transplantation or left ventricular assist device implant for end-stage heart failure
    Racca, Vittorio
    Scaglione, Anna
    De Maria, Renata
    Panzarino, Claudia
    Santangelo, Maria Antonia
    Cipriani, Manlio
    [J]. CLINICAL TRANSPLANTATION, 2020, 34 (08)
  • [12] LEFT VENTRICULAR ASSIST DEVICE DOES NOT IMPROVE CELLULAR IMMUNITY IN END-STAGE HEART FAILURE
    Lundgren, Scott
    Lyden, Elizabeth
    Burdorf, Adam
    Hyden, Marshall
    Stoller, Douglas
    Zolty, Ronald
    Um, John
    Lowes, Brian
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 950 - 950
  • [13] Preliminary experience with the LionHeart left ventricular assist device in patients with end-stage heart failure
    El-Banayosy, A
    Arusoglu, L
    Kizner, L
    Morshuis, M
    Tenderich, G
    Pae, WE
    Körfer, R
    [J]. ANNALS OF THORACIC SURGERY, 2003, 75 (05): : 1469 - 1475
  • [14] An Old Ventricular Assist Device Still Working for Patients With End-Stage Heart Failure in Japan
    Morita, Shigeki
    [J]. CIRCULATION JOURNAL, 2011, 75 (01) : 53 - 54
  • [15] Arterial stiffness is increased in end-stage heart failure patients on a left ventricular assist device
    Schofield, RS
    Pierce, GL
    Nichols, WW
    Aranda, JM
    Pauly, DF
    Klodell, CT
    Hill, JA
    Braith, RW
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 133A - 133A
  • [16] Clinical Experience With HeartWare Left Ventricular Assist Device in Patients With End-Stage Heart Failure
    Popov, Aron Frederik
    Hosseini, Morteza Tavakkoli
    Zych, Bartlomiej
    Mohite, Prashant
    Hards, Rachel
    Krueger, Heike
    Bahrami, Toufan
    Amrani, Mohamed
    Simon, Andre Ruediger
    [J]. ANNALS OF THORACIC SURGERY, 2012, 93 (03): : 810 - 815
  • [17] Long-term use of a left ventricular assist device for end-stage heart failure
    Rose, EA
    Gelijns, AC
    Moskowitz, AJ
    Heitjan, DF
    Stevenson, LW
    Dembitsky, W
    Long, JW
    Ascheim, DD
    Tierney, AR
    Levitan, RG
    Watson, JT
    Meier, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20): : 1435 - 1443
  • [18] Impact of gender in patients with continuous-flow left ventricular assist device therapy in end-stage heart failure
    Zubarevich, Alina
    Szczechowicz, Marcin
    Osswald, Anja
    Arjomandi Rad, Arian
    Vardanyan, Robert
    Pompeu B O Sa, Michel
    Van den Eynde, Jef
    Schmack, Bastian
    Wendt, Daniel
    Koch, Achim
    Pizanis, Nikolaus
    Kamler, Markus
    Ruhparwar, Arjang
    Weymann, Alexander
    Zhigalov, Konstantin
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2021, 44 (12): : 990 - 997
  • [19] The Use of Left Ventricular Assist Devices in End-Stage Heart Failure
    Blair, Ashley
    [J]. CRITICAL CARE NURSING QUARTERLY, 2018, 41 (04) : 376 - 382
  • [20] Heart Transplantation and Left Ventricular Assist Device Therapy: Two Comparable Options in End-Stage Heart Failure?
    Garbade, Jens
    Barten, Markus J.
    Bittner, Hartmuth B.
    Mohr, Friedrich-Wilhelm
    [J]. CLINICAL CARDIOLOGY, 2013, 36 (07) : 378 - 382